Home Page Hot Legal Issues Transvaginal Mesh
Transvaginal Mesh TVT Sling Procedure
Plaintiffs who have filed transvaginal mesh lawsuits claim that the mesh and/or slings used to treat their pelvic organ prolapse or stress urinary incontinence were negligently designed, thereby causing serious side effects such as mesh erosion, organ damage, chronic pain and other vaginal mesh complications.
Transvaginal Mesh Lawsuits
As of January, 2014 more than 40,000 transvaginal mesh lawsuits have been filed against a number of TVM manufacturers, including C.R. Bard, Ethicon (a Johnson & Johnson subsidiary), American Medical Systems (AMS), and Boston Scientific. While some claims have been settled, approximately 3,000 TVM lawsuits a month are currently being filed, mainly against the aforementioned manufacturers.
Many of these lawsuits have been filed in multi-district litigation in federal court in Charleston, West Virginia. A number of bellwether trials have begun proceedings or are scheduled for trial.
(Bellwether trials take place to help both plaintiffs and defendants by determining how juries are likely to respond to evidence and testimony presented. These trials are the norm in complex medical device litigation, particularly in the case of transvaginal mesh products involving multiple medical device companies. Representative cases for bellwether selection include women aged 40 and 60 years old at the time when they had the pelvic mesh surgeries, with three or less revision surgeries. A successful outcome typically indicates a global settlement)
Transvaginal Mesh and Transvaginal Sling are medical devices that are surgically implanted to treat Pelvic Organ Prolapse (POP) and/or Stress Urinary Incontinence(SUI).
Transvaginal Mesh Complication
SUI typically occurs in women after childbirth and/or pregnancy: Due to muscle weakness in the pelvic area, urine leaks from the body during activities such as coughing, laughing, exercising, etc. POP, known as Cystourethrocele, typically occurs in older women whose muscle and tissue groups in the uterus, bladder and pelvic region have become stretched and weakened. As well, women have an increased risk of developing POP with menopause and hysterectomy. Vaginal sling surgery is supposed to strengthen the internal organs and prevent them from coming into contact with each other by implanting mesh tape.
Since 2005 more than 1,000 TVT sling complaints from nine different manufacturers have been reported to the FDA, which culminated in a FDA safety alert in 2008 about serious complications associated with the use of mesh products--also known as pelvic or vaginal mesh and bladder slings-- in treatment of SUI and POP. A number of women have undergone surgeries to have the mesh removed. In 2009 the FDA issued another FDA safety alert. According to the FDA, about 1,500 reports were filed between 2008 and 2010.
In January 2012, the FDA ordered the makers of transvaginal surgical mesh products to study the risks associated with the products. The order came following the recommendation of an FDA advisory panel in September 2011. According to the FDA, between 2008 and 2010 the number of adverse events reports to the FDA about transvaginal meshes increased five times. Not all surgical mesh products are affected by the FDA's order; those that are implanted through the abdomen are not included.
In July 2011, the FDA warned that transvaginal placement of surgical mesh to treat pelvic organ prolapse may carry more risks than other surgical options, without any evidence of greater benefit. The agency stressed that this warning “warning does not apply to mesh placed abdominally, or to treatment for stress urinary incontinence”. An advisory committee will be meeting in September 2011 to discuss the safety and efficacy of the mesh products in those indications.
Before TVT slings were approved, POP and SUI were treated without mesh in a procedure called an abdominal sacrocpopexy, which uses the patient's own ligaments to support weakened muscles. Now, polypropylene mesh is woven through pelvic tissue and placed underneath the urethra, creating a support sling. The tape is designed to support the urethra when pressure is exerted. However, TVT lawsuits claim that many of the transvaginal mesh products have not met reasonable safety standards and that the manufacturers failed to warn of significant risks. Some experts believe the mesh to be a defective design (the Mentor O.B Tape vaginal sling was removed from the market due to a design defect) and that complications develop because it prevents surrounding tissue to receive nutrients. As well, the mesh can erode into the vagina, migrate or shrink, which results in urinary problems, pelvic pain, and infections.
In The Journal Obstetrics & Gynecology (Oct 2005), safety reviewers found that more than 15 percent of the patients who received the mesh experienced erosion, which often results in pain and infections. The study concluded that “Surgeons should be aware of the potential complications of synthetic meshes. Until data on the safety and efficacy of the intravaginal slingplasties are available, these procedures cannot be recommended.”
Transvaginal sling complications include the following:
Currently product liability lawsuits are being filed against a number of transvaginal mesh manufacturers, including Ethicon, a Johnson & Johnson subsidiary, American Medical Systems(AMS), Bard and Boston Scientific. The vaginal mesh lawsuits claim that the vaginal slings were negligently designed, causing pain and other complications.
Transvaginal Mesh Lawsuits by Manufacturer
Ethicon Gynecare transvaginal mesh lawsuits are set to go to trial in August 2014. Ethicon’s Prolift mesh went to trial in New Jersey and ended with the jury awarding the plaintiff $11 million in damages (In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10; In re: Pelvic Mesh Litigation/Bard, No. L-6339-10).
The Ethicon MDL in West Virginia federal court is due for its first bellwether trial in February 2014, which would involve about 13,000 cases. The selected case for the trial is Lewis, et al. v. Johnson & Johnson, et al., 2:12-cv-04301. The Ethicon MDL is In re: Ethicon, Inc., Pelvic Repair System Products Liability Litigation MDL no. 2327 in the U.S. District Court for the Southern District of West Virginia.
More than 6,500 claims have been filed against Bard on behalf of women who suffered severe side effects allegedly due to its Avaulta mesh. Court documents indicate that an additional 940 Avaulta transvaginal mesh lawsuits pending in a multicounty litigation are underway in New Jersey (In re: Pelvic Mesh Litigation/Bard, No. L-6339-10).
AMS mesh cases were scheduled to begin last December. AMS settled a number of cases for $54.5 million, and the company is expected to attempt a global settlement in many more of the 6,000 cases pending in federal court in West Virginia before Judge Joseph R. Goodwin (In re: C.R. Bard, Inc., Pelvic Repair System Products Liability Litigation; MDL-2187, U.S. District Court for the Southern District of West Virginia).
Court documents also show that more than 14,000 vaginal mesh lawsuits pending in the Southern District of West Virginia involve AMS. The first AMS bellwether trial is scheduled to begin on April 7, 2014. The second trial is set for May 5, 2014.
Boston Scientific, based in Massachusetts, has been making medical devices for over 25 years. The company is also responsible for making potentially defective and dangerous transvaginal mesh systems effects, some of which are potentially fatal. Boston Scientific’s transvaginal mesh patch brands include:
The first Boston Scientific bellwether trial is slated for March 10, 2014. The second is set for trial on July 14, 2014.
What is transvaginal mesh?
Transvaginal Mesh Lawsuit FAQ
Transvaginal mesh and transvaginal sling are medical devices used to treat Pelvic Organ Prolapse (POP) and/or Stress Urinary Incontinence (SUI). They are surgically implanted to strengthen the internal organs and prevent POP and/or SUI.
What is the issue with transvaginal meshes?
Lawsuits filed against the companies that make transvaginal meshes allege the meshes were defectively designed, resulting in problems such as erosion of the mesh, organ damage and chronic pain. In some cases, women have had to have the meshes removed.
Complications can include: Mesh erosion into the vagina, bladder, intestines and/or uterus; infection; bleeding; pelvic pain, urinary problems; vaginal scarring; and bowel, bladder or blood vessel perforation during insertion.
According to the FDA, the agency received more than 4,000 injury reports linked to transvaginal meshes between 2005 and 2010.
How do I know if I’ve been injured by transvaginal mesh?
Side effects include persistent vaginal bleeding or discharge, pelvic or groin pain, pain during intercourse, or a recurrence of POP or SUI.
Who makes transvaginal meshes?
There are a variety of companies that make transvaginal meshes. They include Johnson & Johnson’s Ethicon Division, CR Bard, American Medical Systems and Boston Scientific.
Where does litigation with transvaginal meshes stand?
Litigation depends on the company involved in the lawsuit, but so far thousands of lawsuits have been filed against some of the companies that make transvaginal meshes. Many bellwether trials involving allegations about transvaginal meshes were scheduled for early 2014. If you have been injured by a transvaginal mesh, you may still have time to file a lawsuit against the maker of the device implanted in you.
What does the FDA say about transvaginal meshes?
The FDA has warned about the risk associated with transvaginal meshes used for POP and/or SUI. On October 20, 2008, the FDA issued a Public Health Notification warning about the number of adverse events reported to the FDA that were linked to surgical mesh devices. At the time, the FDA noted the possible complications linked to the use of surgical mesh and warned that the use of surgical mesh to treat POP introduced risks that were not seen in traditional non-mesh surgery to treat POP.
On July 13, 2011, the FDA issued a safety communication update, warning that the risks of complications linked to transvaginal mesh were not rare.
Transvaginal Mesh Legal HelpIf you or a loved one has suffered damages in this case, please click the link below and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.
Last updated on Apr-13-14
TRANSVAGINAL MESH LEGAL ARTICLES AND INTERVIEWS
Transvaginal Mesh Is Also a Guy’s Pain
Scottsdale, AZ: Joe’s wife had transvaginal mesh implanted for pelvic organ prolapse about five years ago and they haven’t had “good” sex since. “We try every once in a while but it always ends in frustration,” says Joe. “The woman I love and married to for 29 years doesn’t want to have sex with me anymore. I know couples who have divorced from not having sex and I don’t want to be one of those statistics. [READ MORE]
Prolift Transvaginal Mesh Lawsuit Settled for $11.1 Million
Atlantic City, NJ: A 47-year old nurse has been awarded a total settlement of $11.1 million in her Ethicon Gynecare Prolift transvaginal mesh (TVM) personal injury lawsuit. Linda Gross testified during the trial that following her initial surgery to implant the device, she had 18 subsequent unsuccessful revision procedures. She has described her life after surgery as a “living hell,” alleging that she and thousands of other women have been used as “guinea pigs” by the vaginal mesh maker, Johnson & Johnson [READ MORE]
J&J Transvaginal Mesh Victory a “Fluke”
Dallas, TX: The first of many scheduled court cases alleging that transvaginal mesh devices caused harm to thousands of American women was being closely watched. And a West Virginia judge’s decision in February to dismiss Carolyn Lewis’s personal injury case against Johnson and Johnson (J&J) caused some surprise, but will not deter other cases from going forward [READ MORE]
MORE TRANSVAGINAL MESH LEGAL NEWS
TRANSVAGINAL MESH SETTLEMENTS
IN YOUR OWN WORDS
YOUR TRANSVAGINAL MESH STORIES
Publish your Transvaginal Mesh experience here for our readers to learn from.
READ MORE [ Drugs/Medical Settlements and Legal News ]